Joann Harvey

Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis C

Gary L. Davis, John B. Wong, John G. McHutchison et al. · Hepatology · 2003 · 820 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin

John G. McHutchison, Thierry Poynard, Rafael Esteban et al. · Hepatology · 2002 · 118 citations

Medicine, Infectious Diseases, Molecular Biology +17

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE)

Marcelo Silva, Jorge Luis Poo, Frank Wagner et al. · Journal of Hepatology · 2006 · 106 citations

Medicine, Pharmacokinetics, Pharmacology +15

Impact of weight-based ribavirin with peginterferon alfa-2b in african americans with hepatitis C virus genotype 1

Ira M. Jacobson, Robert S. Brown, Jonathan McCone et al. · Hepatology · 2007 · 76 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL

Jordi Bruix, Thierry Poynard, Massimo Colombo et al. · Journal of Hepatology · 2009 · 36 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17